RxSight, Inc..
RXST.US | Manufacture of medical and dental instruments and supplies
RxSight, Inc. is an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery. The company designs, develops, and commercializes intraocular lenses (IOLs) that can be customized after implantation using a proprietary light adjustable lens (LAL) techno...Show More
Better Health for All
20
RxSight's core product, the Light Adjustable Lens (LAL) system, delivers exceptional health benefits. A study of 21 patients (34 eyes) showed 91% of eyes were within ±0.25 diopters of target and 97% within ±0.50 diopters after light adjustment.
1
Additionally, 94% of eyes had residual refractive cylinder of 0.50 diopters or less.
2
Patient satisfaction averaged 8.8 out of 10, and no adverse events were reported in this study.
3
The company's business is dedicated to improving vision following cataract surgery, with no evidence of harmful products or revenue derived from them.
Fair Money & Economic Opportunity
0
RxSight, Inc. is an ophthalmic medical device company that designs, develops, and commercializes intraocular lenses.
1
The company's core business does not involve lending, insurance, or other financial services. Therefore, all KPIs related to 'Fair Money & Economic Opportunity' are not applicable, as the company does not offer consumer credit products, manage customer finance data, or operate as a financial institution. The articles provided discuss the cost of cataract surgery and the company's products, but do not contain any information relevant to financial inclusion, lending practices, or financial literacy initiatives.
Fair Pay & Worker Respect
30
For fiscal year 2024, RxSight's CEO compensation was $6,982,453, while the median employee pay was $148,932, resulting in a CEO pay ratio of 47:1.
1
An employee survey conducted in 2024 reported an 89% employee approval rate.
2
Fair Trade & Ethical Sourcing
0
The provided articles do not contain specific, quantifiable data points for any of the KPIs under the 'Fair Trade & Ethical Sourcing' value. Information regarding fair-trade certification, audit frequency, forced/child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in supplier contracts, materials risk index, or supplier diversity spend is either explicitly stated as 'no data found,' 'not specified,' or is too vague to meet the quantitative thresholds of the rubric.
1
For example, while the company communicates its commitment regarding conflict minerals to its suppliers, the extent to which this is formalized in enforceable contractual clauses with a specific percentage is not provided.
2
Similarly, the company supports third-party audits but does not specify the frequency of these audits or conduct direct audits, and no specific number of incidents of forced or child labor is mentioned.
3
Honest & Fair Business
0
No evidence available to assess RxSight, Inc. on Honest & Fair Business.
Kind to Animals
0
The provided article details the FDA approval process, clinical trial data, and safety/effectiveness of RxSight, Inc.'s Light Adjustable Lens and Light Delivery Device for human cataract surgery.
1
It contains no information or data points related to animal testing, cruelty-free certifications, animal-derived ingredients, animal agriculture practices, wildlife conservation, or any other aspect of animal welfare relevant to the 'Kind to Animals' value. Therefore, no KPIs can be scored based on the evidence provided.
No War, No Weapons
0
RxSight, Inc. is a medical technology company focused on vision correction through its Light Adjustable Lens (LAL) system. The company's activities are centered around medical devices and have no apparent connection to the arms industry, military contracts, or conflict facilitation.
1
The materiality analysis indicates that RxSight's business model is fundamentally neutral to the 'No War, No Weapons' value. The provided article focuses on compliance and clinical trial results, with no mention of defense-related activities.
2
Insufficient evidence exists to provide a score other than zero.
Planet-Friendly Business
-20
RxSight, Inc. has no specific regulatory actions, violations, fines, or compliance issues mentioned in the provided articles, indicating an exemplary compliance history.
1
Respect for Cultures & Communities
0
The provided articles do not contain any specific data or information relevant to RxSight, Inc.'s performance concerning the ethical value of 'Respect for Cultures & Communities'.
1
Both articles explicitly state that no relevant data for the company or this value is presented.
2
Safe & Smart Tech
-30
In May 2024, RxSight experienced an unauthorized data access incident stemming from a SIM swap attack on an employee's personal cell phone, which led to unauthorized access to the employee's cloud-based work account, emails, and files containing sensitive consumer information, including names and medical information.
1
The company detected unusual activity on May 3, 2024, learned of unauthorized access to personal information on July 10, 2024, and completed its review of compromised files on November 5, 2024, before filing a notice of data breach on November 29, 2024.
2
The company promptly disabled the employee’s account, initiated an investigation with external cybersecurity experts, and reset all passwords.
3
While the company stated its information systems were not interrupted and the incident had no material impact on operations or financial condition, the disclosure timeline was slow.
4
RxSight collects various types of personal information, including health data, and uses cookies and other tracking technologies.
5
Users can opt out of marketing communications and update their information, but the company does not currently respond to "do not track" signals.
6
RxSight states it uses technical, administrative, and physical safeguards to protect information and monitors for fraud and misuse.
7
The company conducts employee training on cybersecurity designed to mitigate threats.
8
RxSight is subject to and states it is in compliance with various regulations, including California Health and Safety Code, AdvaMed Code of Ethics, FDA's QSR/QMSR, EU MDR, ISO certifications, HIPAA, and GDPR, and has a Comprehensive Compliance Program.
9
The company acknowledges increasing cybersecurity risks and vulnerabilities.
10
Zero Waste & Sustainable Products
0
Based on the provided information, there is insufficient evidence to determine RxSight's alignment with the Zero Waste & Sustainable Products value. The materiality analysis suggests a neutral relationship with the value, with a medium level of materiality related to manufacturing and packaging waste. While the provided article from AAO.org discusses sustainable practices in ophthalmology, it does not provide specific information about RxSight's initiatives or performance in waste reduction, product recyclability, or sustainable packaging. Without concrete data on waste diversion rates, recycled content, or waste reduction targets, a score other than 0 cannot be justified.
1